Johns Hopkins Kimmel Cancer Center, Sibley Memorial and Suburban Hospitals

The Ride to Conquer Cancer: Your Dollars at Work


If you have never thought about how cancer may affect you, think again. One in two men and one in three women will be diagnosed with cancer in their lifetime. We’re everywhere you look: there are 13.7 million cancer survivors in the U.S. today, and the number will grow to 22 million by 2020.

Your participation in The Ride to Conquer Cancer® benefiting Johns Hopkins Kimmel Cancer Center, Sibley Memorial and Suburban Hospitals will accelerate the discoveries that are transforming cancer medicine.

The Johns Hopkins Kimmel Cancer Center is one of 41 comprehensive cancer centers designated by the National Cancer Institute and serving more than 10,000 newly diagnosed patients. Nearly 60,000 patients each year come from all over the world to the Kimmel Cancer Center’s Weinberg Building, its main Baltimore location for cancer services. Our experts are dedicated to providing our patients the best treatment and quality of care possible. Patients are seen by multi-disciplinary teams for individualized treatment plans. Learn more about our programs and services.

Experience the Johns Hopkins Kimmel Cancer Center by taking a virtual tour of our clinical care building. "Walk" through our facilities to learn more about services and programs. Prepare for your first visit with this step-by-step guide through our center.

Patients who visit the Kimmel Cancer Center have access to some of the most innovative and advanced therapies in the world. Because Kimmel Cancer Center research scientists and clinicians work closely together, new drugs and treatments developed in the laboratory are quickly transferred to the clinical setting, offering patients constantly improved therapeutic options.

The Kimmel Cancer Center encompasses a wide spectrum of specialty programs for both adults and children coping with cancer, including bone marrow transplantation and new drug development. Additionally, those at high risk for breast, ovarian, colon and other cancers, may seek information about early detection, prevention, and genetic counseling through a comprehensive genetics service.

The Kimmel Cancer Center also offers complete family and patient services that include a Cancer Counseling Center, survivors and palliative care programs, and the 39 suite, Hackerman-Patz Patient and Family Pavilion for patients and their families traveling from out-of-town.

The Johns Hopkins Kimmel Cancer Center is led by world renowned cancer scientist, William G. Nelson, M.D., Ph.D.

Sibley Memorial Hospital, in Northwest Washington, D.C., has a distinguished history of serving the community since its founding in 1890. The Sibley Cancer Center is dedicated to comprehensive and coordinated care with state-of-the-art technology and recognized medical experts on staff. From surgery to radiation oncology to psychosocial support, the Sibley Cancer Center offers patients and their families a calm and private setting and the high level of patient care that is Sibley's hallmark. The Cancer program at Sibley includes the Sullivan Center for Breast Health and the Sibley Center for Gynecologic Oncology & Advanced Pelvic Surgery.

Suburban Hospital was established in 1943. It is based in Montgomery County, Maryland and serves the surrounding areas. Suburban Hospital is affiliated with many local health-care organizations, including the National Institutes of Health. Read more about Suburban’s cancer program.



Over the past four decades, bench to bedside collaborations among Johns Hopkins physician-scientists and researchers have worked to unravel the complex mystery that is cancer.

Scientific discoveries are being used to determine which treatments and screening interventions will work best for each patient. In this new model, the promise of personalized medicine is becoming a reality. The work of Johns Hopkins physicians and scientists are ensuring we get the right treatments to the right patients at the right time. And, it is philanthropy that accelerates this progress. Each year, grant funding becomes scarcer. It is through the generosity of individuals, foundations, and corporations that we continue to make a difference for cancer patients.

Some examples of how Johns Hopkins is changing cancer medicine:

Haploidentical Bone Transplants
Physician-scientists at Johns Hopkins have developed a procedure called a half-matched bone marrow transplant that has been successful in “curing” patients of some cancers and blood disorders like sickle cell anemia. Rather than wiping out a patient’s immune system before transplanting donor bone marrow, doctors administer just enough chemotherapy to suppress the immune system, which keeps patients from rejecting the donated marrow without harming their organs. As a result, the side effects are much milder; only about half of patients may need to be admitted to the hospital. This procedure also greatly expands the potential donor pool, making more patients eligible for the transplant.

To make cancer cells more vulnerable to attack by the immune system, Johns Hopkins researchers are harnessing the immune system with the PD-1 checkpoint inhibitor to treat lung cancer, kidney cancer and melanoma. Physician-scientists at Johns Hopkins also developed an innovative treatment vaccine that seeks out and destroys pancreas cancer cells, one of the most deadly cancers and many times resistant to standard therapy. Watch Dr. Julie Brahmer discuss how PD-1 works.

Next Generation Gene Sequencing and New Screening Tests
Using cervical fluid obtained during routine Pap tests, scientists at the Johns Hopkins Kimmel Cancer Center have developed a test to detect ovarian and endometrial cancers. In a pilot study, the “PapGene” test, which relies on genomic sequencing of cancer-specific mutations, accurately detected them all. This new type of gene sequencing has the potential to lead to more tests that find cancers early and also determine whether treatments are working.

Proceeds from The Ride to Conquer Cancer® ensure the sustainability of this important work as we continue to seek breakthroughs that will directly impact the lives of thousands of people going through cancer treatment.